Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-006042
Filing Date
2025-08-19
Accepted
2025-08-19 16:26:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3323
  Complete submission text file 0001950047-25-006042.txt   4761
Mailing Address C/O ACADIA PHARMACEUTICALS INC. 12830 EL CAMINO REAL, SUITE 400 SAN DIEGO CA 92130
Business Address
Ridloff Elena (Reporting) CIK: 0001772518 (see all company filings)

 

Mailing Address 21 HICKORY DRIVE, SUITE 500 WALTHAM MA 02451
Business Address 21 HICKORY DRIVE, SUITE 500 WALTHAM MA 02451 617-819-2020
Sionna Therapeutics, Inc. (Subject) CIK: 0002036042 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-42504 | Film No.: 251232147
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)